Why the study?
Transcatheter edge-to-edge repair is an emerging minimally invasive treatment for dogs with myxomatous mitral valve disease, but reports on its outcomes are limited.
Does transcatheter edge-to-edge repair (TEER) improve echocardiographic parameters and survival in dogs with myxomatous mitral valve disease?
Does transcatheter edge-to-edge repair (TEER) improve echocardiographic parameters and survival in dogs with myxomatous mitral valve disease?
TEER in dogs with myxomatous mitral valve disease significantly reduces left heart size and regurgitant volume, though it carries a substantial early mortality risk.
BACKGROUND: Transcatheter edge-to-edge repair (TEER) is an emerging minimally invasive mitral valve repair treatment for dogs with myxomatous mitral valve disease (MMVD), but reports on its outcomes are limited. OBJECTIVE: Describe the clinical characteristics and complications in dogs with MMVD undergoing TEER. ANIMALS: Twenty client-owned dogs with MMVD stages B2, C, and D. METHODS: Retrospective case series. Cases were identified by review of hospital medical records between September 2023 and September 2024. RESULTS: Twenty dogs underwent TEER; of these, 13 (65%) survived. Seven dogs died within 9 days because of mitral leaflet tear or single-leaflet device attachment (4/7 dogs, 57.1%), tracheal collapse (1/7 dogs, 14.3%), presumed post-procedure neurologic deficit with a history of hydrocephalus (1/7 dogs, 14.3%), and presumed cardiogenic shock (1/7 dogs, 14.3%). Significant reductions in vertebral heart score (11.6 [9.6-13.1] vs. 11.0 [8.3-11.9] vertebrae; p < 0.01), vertebral left atrial size (2.90 [2.1-3.6] vs. 2.60 [2.0-3.3] vertebrae; p < 0.01), left atrium-to-aortic root ratio (2.09 [1.5-2.5] vs. 1.69 [1.3-2.2]; p < 0.05), left ventricular end-diastolic diameter normalized for body weight (2.1 [1.5-2.3] vs. 1.76 [1.4-2.2]; p < 0.05), regurgitant fraction (77.83 [73.2-83.0] vs. 55.38 [20.5-73.6] %; p < 0.05), and regurgitant volume (3.96 [2.1-6.2] vs. 1.25 [0.4-3.5] ml/kg; p < 0.05) were observed 3 months after TEER. CONCLUSIONS AND CLINICAL IMPORTANCE: Transcatheter edge-to-edge repair resulted in a significant reduction in left atrium and ventricle size and should be further investigated as a potential treatment option for dogs with MMVD.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: